Planet Briefing

First published · Last updated

PT1.07.04 Radiomics Model Based on Synthesized PET for Predicting Neoadjuvant Therapy Pathologic Response in NSCLC (CPT-LC-NEO Trial)

A journal article describing a radiomics model that uses synthesized PET imaging to predict pathological response to neoadjuvant therapy in non-small cell lung cancer. The item is listed as part of the CPT-LC-NEO trial and published by Elsevier BV.

PET Scanner
Illustrative image: PET Scanner — Educate-UK/Wikimedia Commons, CC BY-SA 4.0

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
5/10
Geographic reach
1/10
Global importance
3/10
Impact magnitude
2/10
Positivity
5/10
Urgency
1/10

Why it matters

The paper presents a medical-imaging prediction model aimed at assessing treatment response in NSCLC.

Sources

Report an issue